arch42

EN_01450763_1945

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

(FILES) In this file photo taken on April 8, 2020 one vial of the drug Remdesivir is seen during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, amidst the new coronavirus COVID-19 pandemic. - The US Food and Drug Administration on October 22, 2020 granted full approval to the antiviral drug Remdesivir as a treatment for patients hospitalized with Covid-19, its manufacturer Gilead said, following conditional authorization granted in May. (Photo by Ulrich Perrey / POOL / AFP)

headline arch42

created date 2020-04-08

credit ULRICH PERREY/AFP/East News

source AFP

byline ULRICH PERREY

original transmission reference AFP_8TN364

weight 2,68MB

size 25cm x 18cm by 300dpi

keywords - Show

2020, 22, 8, A, ABOUT, ADMINISTRATION, AMIDST, AND, ANTIVIRAL, APPROVAL, APRIL, AS, AT, AUTHORIZATION, BY, CONDITIONAL, CONFERENCE, CORONAVIRUS, COVID-19, DRUG, DURING, EBOLA, ECONOMY, EPIDEMIC, EPPENDORF, FILE, FILES, FOLLOWING, FOOD, FOR, FULL, GERMANY, GILEAD, GRANTED, HAMBURG, HEALTH, HORIZONTAL, HOSPITAL, HOSPITALIZED, ILL, ILLUSTRATION, IN, IS, ITS, LOGO, MANUFACTURER, MAY, NEW, NORTHERN, OCTOBER, OF, ON, ONE, PANDEMIC, PANDEMIE, PARTICULARLY, PATIENTS, PERREY, POOL, PRESS, REMDESIVIR, SAID, SEEN, SEVERELY, SMARTPHONE, START, STUDY, TAKEN, THE, THIS, TO, TREATMENT, UKE, ULRICH, UNIVERSITY, US, VIAL, WITH,